17 Nov 2023
Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries Yourgene’s LightBench® instrument offers precise and accurate target enrichment of PacBio HiFi SMRTbell sequencing libraries increasing HiFi sequencing yields Manchester, UK, 17 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group,…
09 Nov 2023
Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents Manchester, UK, and Rabat, MOROCCO, 09 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT)…
07 Nov 2023
IVDR certification achieved for DPYD genotyping assay First product of its kind to conform with new IVDR requirements Yourgene Health (part of the Novacyt group), an international specialist in clinical diagnostics, confirms – IVDR accreditation under the new requirements of the In Vitro Diagnostic Regulation (“IVDR”) for its DPYD genotyping assay, which helps identify cancer patients at…
25 Oct 2023
25 Oct 2023
05 Sep 2023
Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow Manchester, UK, and SINGAPORE, 5 September 2023: Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today…
Pour les nouvelles des investisseurs via RNS, veuillez cliquer sur le bouton ci-dessous.